Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

This is a single-arm, open label, phase 1 study in subjects with beta-thalassemia. This study will evaluate the safety and efficacy of preconditioning-free super-transplantation on beta-thalassemia pediatric patients.

NCT Number	NCT06734520
Lead Sponsor	Guangzhou Women and Children's Medical Center
Conditions	Thalassemia Majors (Beta-Thalassemia Major), Haplo-identical Donors
Enrollment	3 participants
Start Date	2024-10-01
Primary Completion	2029-07-01 (estimated)
Study Completion	2029-07-01 (estimated)
Updated on ClinicalTrials.gov	2024-12-16